These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6264247)

  • 1. Multiple benzodiazepine receptors: evidence of dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives).
    Le Fur G; Mizoule J; Burgevin MC; Ferris O; Heaulme M; Gauthier A; Guérémy C; Uzan A
    Life Sci; 1981 Mar; 28(13):1439-48. PubMed ID: 6264247
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anxiety receptors: new pharmacological approach (author's transl)].
    Le Fur G
    Encephale; 1982; 8(2):145-50. PubMed ID: 6125375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical evidence that 2-phenyl-4[(4-piperidinyl) ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptors.
    Benavides J; Malgouris C; Flamier A; Tur C; Quarteronet D; Begassat F; Camelin JC; Uzan A; Gueremy C; Le Fur G
    Neuropharmacology; 1984 Oct; 23(10):1129-36. PubMed ID: 6097832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels.
    Möhler H; Burkard WP; Keller HH; Richards JG; Haefely W
    J Neurochem; 1981 Sep; 37(3):714-22. PubMed ID: 6268754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain receptors and zopiclone.
    Blanchard JC; Boireau A; Julou L
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():59-69. PubMed ID: 6329982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors.
    Trifiletti RR; Snyder SH
    Mol Pharmacol; 1984 Nov; 26(3):458-69. PubMed ID: 6092896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the reversal of the anticonflict effect of phenobarbital by beta-CCE and FG 7142 indicate benzodiazepine receptor-mediated anxiogenic properties?
    Petersen EN; Paschelke G; Kehr W; Nielsen M; Braestrup C
    Eur J Pharmacol; 1982 Aug; 82(3-4):217-21. PubMed ID: 6290238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and electroencephalographic effects of zopiclone, a cyclopyrrolone derivative.
    Ueki S; Watanabe S; Yamamoto T; Kataoka Y; Shibata S; Shibata K; Ohta H; Shimazoe T; Kawamoto H
    Jpn J Pharmacol; 1987 Mar; 43(3):309-26. PubMed ID: 3495682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel non-benzodiazepine anxiolytics.
    Goldberg ME; Salama AI; Patel JB; Malick JB
    Neuropharmacology; 1983 Dec; 22(12B):1499-504. PubMed ID: 6142427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Carbolines and benzodiazepine receptors: structure-activity relationships and pharmacologic activity.
    Skolnick P; Williams EF; Cook JM; Cain M; Rice KC; Mendelson WB; Crawley JN; Paul SM
    Prog Clin Biol Res; 1982; 90():233-52. PubMed ID: 6287491
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effects of kainic acid on benzodiazepine receptors, GABA receptors, and GABA-modulin in the cerebellar cortex.
    Biggio G; Corda MG; De Montis G; Gessa GL
    Adv Biochem Psychopharmacol; 1980; 21():265-70. PubMed ID: 6246741
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors.
    Blanchard JC; Boireau A; Garret C; Julou L
    Life Sci; 1979 Jun; 24(26):2417-20. PubMed ID: 39209
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavioral and electroencephalographic effects of zopiclone, a cyclopyrrolone derivative].
    Ueki S; Watanabe S; Yamamoto T; Kataoka Y; Shibata S; Shibata K; Oota H; Nakanishi H; Kiyota Y
    Fukuoka Igaku Zasshi; 1983 Aug; 74(8):550-67. PubMed ID: 6686589
    [No Abstract]   [Full Text] [Related]  

  • 15. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic and behavioral effects of EMD 28422: a novel purine which enhances (3H) diazepam binding to brain benzodiazepine receptors.
    Skolnick P; Lock KL; Paugh B; Marangos P; Windsor R; Paul S
    Pharmacol Biochem Behav; 1980 May; 12(5):685-9. PubMed ID: 7393962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micromolar affinity benzodiazepine receptors: identification and characterization in central nervous system.
    Bowling AC; DeLorenzo RJ
    Science; 1982 Jun; 216(4551):1247-50. PubMed ID: 6281893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine inhibition of the calcium-calmodulin protein kinase system in brain membrane.
    DeLorenzo RJ; Burdette S; Holderness J
    Science; 1981 Jul; 213(4507):546-9. PubMed ID: 6264605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evidence that PK 8165 behaves as a partial agonist of brain type benzodiazepine receptors.
    Mizoule J; Rataud J; Uzan A; Mazadier M; Daniel M; Gauthier A; Ollat C; Gueremy C; Renault C; Dubroeucq MC
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):189-97. PubMed ID: 6095778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.